Hanlin Gao - Nov 16, 2022 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Signature
/s/ Paul Kim as Attorney-in-Fact
Stock symbol
FLGT
Transactions as of
Nov 16, 2022
Transactions value $
-$12,275
Form type
4
Date filed
11/18/2022, 03:12 PM
Previous filing
Nov 9, 2022
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGT Common Stock Sale -$12.3K -342 -0.04% $35.89 907K Nov 16, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2019.
F2 The shares were sold in multiple transactions at prices ranging from $35.515 to $36.370, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.